Robert James Wills, Director at Milestone Pharmaceuticals Inc. (MIST), bought 15,000 shares at $4.93 ($74K) on 2022-10-19, disclosed to the SEC on 2022-10-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ONCT | BUY | 2024-04-10 | $28K | — | Filing → |
| ONCT | BUY | 2024-04-01 | $117K | — | Filing → |
| ONCT | SELL | 2024-02-27 | $9K | — | Filing → |